🇪🇺 RSV prefusion F protein-based vaccine in European Union

RSV prefusion F protein-based vaccine (rsv-prefusion-f-protein-based-vaccine) regulatory status in European Union.

Marketing authorisation

EMA

  • Status: approved

RSV prefusion F protein-based vaccine in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Immunology approved in European Union

Frequently asked questions

Is RSV prefusion F protein-based vaccine approved in European Union?

Yes. EMA has authorised it.

Who is the marketing authorisation holder for RSV prefusion F protein-based vaccine in European Union?

Pfizer Inc. is the originator. The local marketing authorisation holder may differ — check the official source linked above.